Skip to content
ClinCalc Pro
Menu
ACE inhibitor (short-acting)

Captopril

Brand names: Capoten

Captopril is a short-acting angiotensin-converting enzyme (ACE) inhibitor used in hypertension, heart failure, after myocardial infarction and in diabetic nephropathy.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits ACE, reducing the conversion of angiotensin I to angiotensin II and decreasing aldosterone secretion, producing vasodilatation and reduced sodium and water retention.

Prescribing in practice

  • Contraindicated in pregnancy due to the risk of fetal toxicity from drugs acting on the renin-angiotensin system.
  • Can cause hyperkalaemia, renal impairment and first-dose hypotension, with particular caution in volume depletion, renal artery stenosis and concomitant potassium-sparing agents.
  • May cause a persistent dry cough and, rarely, angioedema, which requires immediate discontinuation.

Monitoring

Monitor blood pressure, renal function and serum potassium before and after starting treatment and following dose changes.

Counselling the patient

  • Tell your prescriber immediately if you become pregnant, as this medicine must be stopped.
  • Report any swelling of the face, lips or throat urgently, and mention a persistent dry cough.

Evidence & guidelines

ACE inhibitors including captopril improve outcomes in heart failure and after myocardial infarction, as shown in landmark trials such as SAVE.

Reference: SmPC Capoten; NICE NG136 (Hypertension); NICE NG106 (Chronic HF); SAVE trial NEJM 1992; 327:669-77; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.